Companies To Watch
The Companies to Watch column spotlights small, entrepreneurial biopharma companies that are developing their own products (not just a platform) with little or no press coverage to date, and offering an interesting story involving useful business lessons.
Companies To Watch: Orca Bio
Orca Bio is creating a new cell therapy aimed at bringing rebirth to stem-cell transplantation.
Companies To Watch: Sonoma Biotherapeutics
Sonoma Biotherapeutics is bioengineering T cells to create potential cures for autoimmune and inflammatory conditions.
Companies To Watch: KaliVir Immunotherapeutics
KaliVir Immunotherapeutics is engineering oncolytic viruses with novel transgenes, and joining them to other immunotherapies, to defeat cancer and cancer relapse.
Companies To Watch: Hummingbird Bioscience
Hummingbird Bioscience is joining the forces of computational and systems biology to fight cancer and autoimmune disease.
Companies To Watch: Corner Therapeutics
Corner Therapeutics is focused on discovering new small molecules that could mimic the body’s natural immune response to generate the robust T-cell response.
Companies To Watch: Ocelot Bio
Ocelot Bio is focusing a single drug on multiple complications of end-stage liver disease.
Companies To Watch: iTolerance
iTolerance is dedicated to curing diabetes and other conditions by inducing local immune tolerance in implantation.
Companies To Watch: CytoAgents
CytoAgents is combatting the broad areas of disease stemming from a common cause: cytokine release syndrome.
Companies To Watch: Viking Therapeutics
Viking Therapeutics is a broad-target contender for treating NASH in a pipeline of new drugs for metabolic and endocrine disorders.
Companies To Watch: Priothera
Priothera is bent on boosting the safety and effectiveness of hematopoietic stem cell transplantation for blood cancers.
Companies To Watch: Mirum Pharmaceuticals
Mirum Pharmaceuticals: Two drugs, one FDA approved, together taking on a half-dozen rare liver diseases.
Companies To Watch: CinCor Pharma
CinCor Pharma is uncovering a great potential for combatting treatment-resistant and uncontrolled hypertension.
Companies To Watch: Castle Creek Biosciences
For Castle Creek Biosciences, there are many stakes at play in targeting rare skin, connective tissue, liver, and metabolic disorders.
Companies To Watch: Global Blood Therapeutics
Global Blood Therapeutics is intertwining science, business, and social missions to make progress against sickle cell disease.
IN THIS MONTH'S ISSUE
BEYOND THE PRINTED PAGE
2023 Manufacturing And Supply Chain Outlook: Additional Insights12/16/2022
Additional executive responses to our 2023 manufacturing and supply chain outlook questions.
2023 Finance And Funding Outlook: Additional Insights Part 212/9/2022
Additional experts weigh in on Life Science Leader's 2023 finance and funding outlook questions.
2023 Finance And Funding Outlook: Additional Insights Part 112/2/2022
Biopharma executives offer options, tips and strategies for navigating finance and funding challenges in 2023.